NCT01891331View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Candidiasis, Vulvovaginal

Interventions

DRUG

VT-1161

DRUG

Fluconazole

Trial Locations (8)

11203

SUNY Downstate Medical Center, Brooklyn

19102

Drexel Vaginitis Center, Philadelphia

27103

Lyndhurst Clinical Research, Winston-Salem

27607

Lyndhurst Clinical Research, Raleigh

33161

Healthcare Clinical Data, Inc, North Miami

33461

Altus Research, Lake Worth

75062

Brownstone Clinical Trials, LLC, Irving

98104

Harborview ID Research Clinic, Seattle

All Listed Sponsors

lead

Viamet

INDUSTRY

NCT01891331 - A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) | Biotech Hunter | Biotech Hunter